What is Becton, Dickinson and Co.'s earnings per share (EPS)?

Becton, Dickinson and Co. (BDX) reported diluted earnings per share of $5.82 for fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Becton, Dickinson and Co. (BDX) Financials

BDX

Trailing 12 months to June 30, 2026

Revenue $22.4B +13.1% YoY

Net Income $941.0M -40.6% YoY

EPS (Diluted) $3.32 -39.4% YoY

Free Cash Flow $3.2B +54.2% YoY

Market Cap $48.2B as of Oct 2, 2026

Price / Sales 2.1x on $22.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 51.2x on $941.0M net income, trailing 12 months to June 30, 2026

Price / Book 2.0x on $24.4B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BDX SEC filings page.

Becton, Dickinson and Co. (BDX) reported $22.4B in revenue over the twelve months to Jun 30, 2026, up 13.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BDX FY2025 2026-08-29

Revenue expansion reaches gross profit, but higher overhead and financing costs prevent net earnings from scaling with it.

Revenue increased 14.2% from FY2021 to FY2025 while net income fell 19.8%; that divergence places the strain below gross profit rather than in core production economics. Gross margin stayed broadly stable, while 2025 SG&A reached $5.3B and interest expense $613M, showing where added sales were absorbed.

Operating cash flow of $3.4B exceeded net income of $1.7B in FY2025, indicating that non-cash charges and working-capital movements materially affect earnings quality. After $760M of capital expenditures, free cash flow was $2.7B, so reinvestment consumed only a minority of operating inflow.

Debt-to-equity was 0.7x in FY2025, making borrowing a meaningful funding layer alongside equity rather than the sole engine of expansion. The current ratio fell from 1.3x in FY2023 to 1.1x in FY2025, narrowing short-term asset coverage even as total liabilities remained below total assets.

Financial Health Signals

Financial Health Score 52/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Becton, Dickinson and Co.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Becton, Dickinson and Co. has an operating margin of 11.8%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is down from 11.9% the prior year.

Growth

Becton, Dickinson and Co.'s revenue grew 8.2% year-over-year to $21.8B, a solid pace of expansion. This earns a growth score of 55/100.

Leverage

Becton, Dickinson and Co. has elevated debt relative to equity (D/E of 0.69), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 19/100, reflecting increased financial risk.

Liquidity

Becton, Dickinson and Co.'s current ratio of 1.11 is below the typical benchmark, resulting in a score of 24/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Becton, Dickinson and Co. converts 12.2% of revenue into free cash flow ($2.7B). This strong cash generation earns a score of 73/100.

Returns

Becton, Dickinson and Co.'s ROE of 6.6% shows moderate profitability relative to equity, earning a score of 63/100. This is unchanged from the prior year.

Altman Z-Score Grey Zone

1.95

Becton, Dickinson and Co. scores 1.95, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Becton, Dickinson and Co. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.04x

For every $1 of reported earnings, Becton, Dickinson and Co. generates $2.04 in operating cash flow ($3.4B OCF vs $1.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.21x

Becton, Dickinson and Co. earns $4.21 in operating income for every $1 of interest expense ($2.6B vs $613.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.0B

YoY+5.4%

QoQ+5.7%

5Y CAGR+1.6%

10Y CAGR+4.5%

Becton, Dickinson and Co. generated $5.0B in revenue in Q3 2026. This represents an increase of 5.4% from the same quarter a year earlier. Against the prior quarter it is up 5.7%.

EBITDA

$1.2B

YoY-6.6%

QoQ+87.0%

5Y CAGR+3.6%

Becton, Dickinson and Co.'s EBITDA was $1.2B in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.6% from the same quarter a year earlier. Against the prior quarter it is up 87.0%.

Net Income

$377.0M

YoY-34.3%

QoQ+221.2%

5Y CAGR-6.4%

10Y CAGR-0.3%

Becton, Dickinson and Co. reported $377.0M in net income in Q3 2026. This represents a decrease of 34.3% from the same quarter a year earlier. Against the prior quarter it is up 221.2%.

EPS (Diluted)

$1.37

YoY-31.5%

QoQ+223.4%

5Y CAGR-4.4%

10Y CAGR-2.7%

Becton, Dickinson and Co. earned $1.37 per diluted share (EPS) in Q3 2026. This represents a decrease of 31.5% from the same quarter a year earlier. Against the prior quarter it is up 223.4%.

Cash & Balance Sheet

Free Cash Flow

$633.0M

YoY-31.6%

QoQ+15.9%

5Y CAGR+14.5%

10Y CAGR-0.8%

Becton, Dickinson and Co. generated $633.0M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 31.6% from the same quarter a year earlier. Against the prior quarter it is up 15.9%.

Cash & Debt

$708.0M

YoY-3.7%

QoQ-12.9%

5Y CAGR-25.8%

10Y CAGR-8.3%

Becton, Dickinson and Co. held $708.0M in cash against $13.5B in long-term debt as of Q3 2026.

Dividends Per Share

$1.05

YoY+1.0%

QoQ0.0%

Becton, Dickinson and Co. paid $1.05 per share in dividends in Q3 2026. This represents an increase of 1.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

272M

YoY-5.0%

QoQ-1.1%

5Y CAGR-1.1%

10Y CAGR+2.5%

Becton, Dickinson and Co. had 272M shares outstanding in Q3 2026. This represents a decrease of 5.0% from the same quarter a year earlier. Against the prior quarter it is down 1.1%.

Margins & Returns

Gross Margin

46.5%

YoY-0.8pp

QoQ+0.8pp

5Y change+4.0pp

10Y change-1.9pp

Becton, Dickinson and Co.'s gross margin was 46.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.

Operating Margin

13.3%

YoY-2.3pp

QoQ+11.3pp

5Y change+2.6pp

Becton, Dickinson and Co.'s operating margin was 13.3% in Q3 2026, reflecting core business profitability. This is down 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.3 percentage points.

Net Margin

7.6%

YoY-4.6pp

QoQ+14.2pp

5Y change-3.8pp

10Y change-4.6pp

Becton, Dickinson and Co.'s net profit margin was 7.6% in Q3 2026, showing the share of revenue converted to profit. This is down 4.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.2 percentage points.

Return on Equity

1.5%

YoY-0.7pp

QoQ+2.8pp

5Y change-0.6pp

10Y change-3.3pp

Becton, Dickinson and Co.'s ROE was 1.5% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.8 percentage points.

Capital Allocation

R&D Spending

$258.0M

YoY+12.2%

QoQ+3.6%

5Y CAGR-4.8%

Becton, Dickinson and Co. invested $258.0M in research and development in Q3 2026. This represents an increase of 12.2% from the same quarter a year earlier. Against the prior quarter it is up 3.6%.

Share Buybacks

QoQ-100.0%

Becton, Dickinson and Co. repurchased no shares in Q3 2026. Against the prior quarter it is down 100.0%.

Capital Expenditures

$143.0M

YoY-12.8%

QoQ+14.4%

5Y CAGR-10.1%

10Y CAGR-0.3%

Becton, Dickinson and Co. invested $143.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 12.8% from the same quarter a year earlier. Against the prior quarter it is up 14.4%.

BDX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BDX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$22.4B	$21.8B+8.2%	$20.2B+4.2%	$19.4B+2.7%	$18.9B-1.4%	$19.1B+19.0%	$16.1B-7.0%	$17.3B+8.2%	$16.0B+32.2%	$12.1B-3.1%	$12.5B+21.4%	$10.3B+21.7%	$8.4B+4.9%	$8.1B+4.5%	$7.7B+1.6%	$7.6B
Cost of Revenue	$11.9B	$11.9B+7.8%	$11.1B-1.3%	$11.2B+7.8%	$10.4B-1.0%	$10.5B+13.2%	$9.3B+3.0%	$9.0B+3.3%	$8.7B+42.2%	$6.1B-5.6%	$6.5B+16.2%	$5.6B+34.8%	$4.1B+6.7%	$3.9B+3.4%	$3.8B+3.6%	$3.6B
Gross Profit	$10.5B	$9.9B+8.8%	$9.1B+11.7%	$8.2B-3.6%	$8.5B-1.8%	$8.6B+13.9%	$7.6B-8.6%	$8.3B+14.0%	$7.3B+22.3%	$5.9B-0.8%	$6.0B+27.6%	$4.7B+9.2%	$4.3B+3.1%	$4.2B+5.5%	$4.0B-0.2%	$4.0B
R&D Expenses	$1.3B	$1.3B+6.3%	$1.2B-3.8%	$1.2B-1.5%	$1.3B-1.8%	$1.3B+23.1%	$1.0B-2.2%	$1.1B+5.8%	$1.0B+30.4%	$770.0M-7.0%	$828.0M+31.0%	$632.0M+14.9%	$550.0M+11.3%	$494.0M+4.7%	$472.0M+0.4%	$470.0M
SG&A Expenses	$5.5B	$5.3B+8.7%	$4.9B+2.9%	$4.7B+0.2%	$4.7B-0.2%	$4.7B+12.8%	$4.2B-3.4%	$4.3B+7.9%	$4.0B+38.1%	$2.9B-3.2%	$3.0B+17.2%	$2.6B+19.5%	$2.1B-11.4%	$2.4B+25.9%	$1.9B+5.4%	$1.8B
Operating Income	$2.3B	$2.6B+7.6%	$2.4B+13.5%	$2.1B-7.5%	$2.3B+1.4%	$2.3B+146.7%	$912.0M-48.2%	$1.8B+16.6%	$1.5B-0.9%	$1.5B+6.4%	$1.4B+33.1%	$1.1B-33.1%	$1.6B+28.1%	$1.3B-19.5%	$1.6B-6.5%	$1.7B
EBITDA	N/A	$5.0B+7.6%	$4.7B+6.5%	$4.4B-2.5%	$4.5B+0.7%	$4.5B+48.0%	$3.0B-24.6%	$4.0B+15.1%	$3.5B+33.6%	$2.6B+2.6%	$2.5B+29.5%	$2.0B-9.4%	$2.2B+20.4%	$1.8B-13.0%	$2.1B-4.2%	$2.2B
Interest Expense	$590.0M	$613.0M+16.1%	$528.0M+16.8%	$452.0M+13.6%	$398.0M-15.1%	$469.0M-11.2%	$528.0M-17.4%	$639.0M-9.5%	$706.0M+35.5%	$521.0M+34.3%	$388.0M+4.6%	$371.0M+174.8%	$135.0M-2.2%	$138.0M+2.2%	$135.0M+60.7%	$84.0M
Income Tax	$228.0M	$203.0M-32.3%	$300.0M+127.3%	$132.0M-10.8%	$148.0M+68.2%	$88.0M+41.9%	$62.0M+208.8%	-$57.0M-106.6%	$862.0M+795.2%	-$124.0M-227.8%	$97.0M+120.5%	$44.0M-86.9%	$337.0M+42.8%	$236.0M-35.0%	$363.0M-12.9%	$417.0M
Net Income	$941.0M	$1.7B-1.6%	$1.7B+14.9%	$1.5B-16.6%	$1.8B-15.0%	$2.1B+139.4%	$874.0M-29.1%	$1.2B+296.5%	$311.0M-71.7%	$1.1B+12.7%	$976.0M+40.4%	$695.0M-41.4%	$1.2B-8.4%	$1.3B+10.5%	$1.2B-7.9%	$1.3B
EPS (Basic)	N/A	$5.83-0.9%	$5.88+18.3%	$4.97-16.2%	$5.93-14.3%	$6.92+151.6%	$2.75-31.4%	$4.01+546.8%	$0.62-86.8%	$4.70+2.4%	$4.59+33.8%	$3.43-44.0%	$6.13-7.5%	$6.63+16.5%	$5.69-1.0%	$5.75
EPS (Diluted)	$3.32	$5.82-0.7%	$5.86+18.6%	$4.94-16.0%	$5.88-14.2%	$6.85+152.8%	$2.71-31.2%	$3.94	$0.60	$4.60+2.4%	$4.49+34.0%	$3.35-44.1%	$5.99-7.7%	$6.49+16.1%	$5.59-0.5%	$5.62
Diluted Shares (Avg)	N/A	289M-0.9%	291M+0.9%	288M+0.4%	287M-1.6%	292M+3.4%	282M+2.8%	275M	265M	224M+2.8%	218M+4.8%	208M+5.0%	198M-0.7%	199M-4.8%	209M-7.6%	226M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$5.0B+5.4%	$4.7B+5.2%	$5.3B+1.6%	$7.5B+37.3%	$4.7B-5.3%	$4.5B-11.2%	$5.2B+9.8%	$5.4B+6.9%
Cost of Revenue	$2.7B+7.1%	$2.6B-2.3%	$2.8B-3.1%	$3.9B+31.3%	$2.5B-7.2%	$2.6B-4.5%	$2.9B+9.5%	$3.0B-12.9%
Gross Profit	$2.3B+3.6%	$2.2B+15.7%	$2.4B+7.9%	$3.6B+44.5%	$2.2B-3.1%	$1.9B-19.2%	$2.2B+10.3%	$2.5B+46.1%
R&D Expenses	$258.0M+12.2%	$249.0M+7.3%	$306.0M-10.8%	$460.0M+52.3%	$230.0M-23.1%	$232.0M-22.4%	$343.0M+18.3%	$302.0M+7.5%
SG&A Expenses	$1.3B+8.4%	$1.2B+8.6%	$1.4B+5.7%	$1.7B+33.9%	$1.2B-2.8%	$1.1B-6.4%	$1.3B+8.7%	$1.3B+10.4%
Operating Income	$663.0M-10.3%	$93.0M-75.7%	$552.0M+21.9%	$1.0B+61.4%	$739.0M+22.8%	$383.0M-47.8%	$453.0M+3.2%	$622.0M+78.2%
EBITDA	$1.2B-6.6%	$656.0M-30.9%	$1.2B+10.0%	$1.7B+42.1%	$1.3B+12.3%	$950.0M-27.2%	$1.1B+6.0%	$1.2B+29.1%
Interest Expense	$132.0M-13.2%	$149.0M-0.7%	$153.0M-1.3%	$156.0M+0.6%	$152.0M+10.9%	$150.0M+20.0%	$155.0M+39.6%	$155.0M+37.2%
Income Tax	$102.0M-13.6%	$76.0M+76.7%	$11.0M+266.7%	$39.0M-65.8%	$118.0M+807.7%	$43.0M-55.2%	$3.0M-96.1%	$114.0M+307.1%
Net Income	$377.0M-34.3%	-$311.0M-201.0%	$382.0M+26.1%	$493.0M+23.3%	$574.0M+17.9%	$308.0M-42.6%	$303.0M+7.8%	$400.0M+270.4%
EPS (Basic)	$1.37-31.5%	-$1.11-203.7%	$1.34+27.6%	$1.72+24.6%	$2.00+19.0%	$1.07-42.2%	$1.05+8.2%	$1.38+294.3%
EPS (Diluted)	$1.37-31.5%	-$1.11-203.7%	$1.34+28.8%	$1.72+25.5%	$2.00+19.0%	$1.07-42.2%	$1.04+8.3%	$1.37+302.9%
Diluted Shares (Avg)	275M-4.2%	281M-2.5%	286M-1.6%	N/A	287M-1.0%	288M-0.9%	290M-0.3%	N/A

BDX Balance Sheet

BDX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$55.3B-3.4%	$57.3B+8.5%	$52.8B-0.3%	$52.9B-1.7%	$53.9B-0.3%	$54.0B+4.3%	$51.8B-4.0%	$53.9B+42.9%	$37.7B+47.5%	$25.6B-3.4%	$26.5B+113.8%	$12.4B+1.9%	$12.1B+6.9%	$11.4B+8.9%	$10.4B
Current Assets	$9.3B-11.6%	$10.5B+20.7%	$8.7B+6.6%	$8.1B-7.9%	$8.8B-1.5%	$9.0B+34.6%	$6.7B-10.1%	$7.4B-60.2%	$18.6B+192.6%	$6.4B+12.5%	$5.7B-7.7%	$6.1B+4.4%	$5.9B+10.4%	$5.3B+14.0%	$4.7B
Cash & Equivalents	$567.0M-67.0%	$1.7B+21.3%	$1.4B+40.8%	$1.0B-55.9%	$2.3B-19.2%	$2.8B+427.1%	$536.0M-53.0%	$1.1B-92.0%	$14.2B+820.1%	$1.5B+8.2%	$1.4B-23.5%	$1.9B-1.5%	$1.9B+13.1%	$1.7B+42.2%	$1.2B
Short-Term Investments	$8.0M-98.2%	$445.0M+5462.5%	$8.0M0.0%	$8.0M-33.3%	$12.0M-40.0%	$20.0M-33.3%	$30.0M+76.5%	$17.0M-19.0%	$21.0M-22.2%	$27.0M+35.0%	$20.0M-97.7%	$884.0M+23.1%	$718.0M+40.8%	$510.0M+31.4%	$388.0M
Inventory	$3.1B-18.1%	$3.8B+17.4%	$3.3B+1.5%	$3.2B+17.5%	$2.7B0.0%	$2.7B+6.4%	$2.6B+5.2%	$2.5B+34.8%	$1.8B+5.8%	$1.7B-12.3%	$2.0B+31.0%	$1.5B+6.6%	$1.4B+13.0%	$1.2B-0.3%	$1.2B
Accounts Receivable	$2.4B-21.0%	$3.0B+19.7%	$2.5B+15.7%	$2.2B-6.8%	$2.4B-2.0%	$2.4B+2.3%	$2.3B+1.1%	$2.3B+33.0%	$1.7B+7.8%	$1.6B0.0%	$1.6B	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$26.0B-1.9%	$26.5B+7.9%	$24.5B-0.4%	$24.6B+3.1%	$23.9B+1.2%	$23.6B+1.0%	$23.4B-0.9%	$23.6B+212.0%	$7.6B+1.9%	$7.4B-1.6%	$7.5B+591.5%	$1.1B-1.7%	$1.1B+3.1%	$1.1B+8.6%	$991.1M
Total Liabilities	$29.9B-4.7%	$31.4B+16.4%	$27.0B-2.4%	$27.7B-8.4%	$30.2B-0.2%	$30.2B-1.4%	$30.7B-6.8%	$32.9B+32.8%	$24.8B+38.1%	$18.0B-7.0%	$19.3B+163.5%	$7.3B+3.2%	$7.1B-1.6%	$7.2B+29.0%	$5.6B
Current Liabilities	$8.3B-7.2%	$9.0B+34.9%	$6.6B-15.0%	$7.8B+17.9%	$6.6B+13.5%	$5.8B+3.2%	$5.7B-21.6%	$7.2B+115.9%	$3.3B-24.0%	$4.4B+0.4%	$4.4B+96.0%	$2.2B+4.9%	$2.1B+7.7%	$2.0B+8.5%	$1.8B
Non-Current Liabilities	$21.6B-3.6%	$22.4B+10.3%	$20.3B+2.5%	$19.8B-15.8%	$23.6B-3.5%	$24.4B-2.5%	$25.0B-2.6%	$25.7B+19.8%	$21.4B+58.2%	$13.6B-9.2%	$14.9B+193.0%	$5.1B+2.4%	$5.0B-5.2%	$5.2B+38.9%	$3.8B
Long-Term Debt	$17.6B-1.8%	$17.9B+21.7%	$14.7B+6.1%	$13.9B-18.8%	$17.1B-0.7%	$17.2B-4.7%	$18.1B-4.3%	$18.9B+1.2%	$18.7B+76.9%	$10.6B-7.2%	$11.4B+201.8%	$3.8B+0.1%	$3.8B+0.1%	$3.8B+51.4%	$2.5B
Total Equity	$25.4B-1.9%	$25.9B+0.4%	$25.8B+2.0%	$25.3B+6.8%	$23.7B-0.4%	$23.8B+12.7%	$21.1B+0.4%	$21.0B+62.1%	$12.9B+69.6%	$7.6B+6.5%	$7.2B+41.8%	$5.1B+0.2%	$5.0B+21.9%	$4.1B-14.3%	$4.8B
Retained Earnings	$16.6B+3.0%	$16.1B+3.9%	$15.5B+2.5%	$15.2B+9.6%	$13.8B+8.1%	$12.8B-0.9%	$12.9B+2.5%	$12.6B-3.9%	$13.1B+3.0%	$12.7B+3.4%	$12.3B+1.7%	$12.1B+6.7%	$11.3B+8.7%	$10.4B+8.3%	$9.6B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$50.7B-7.6%	$50.8B-6.7%	$54.8B+0.3%	$55.3B-3.4%	$54.9B-1.2%	$54.5B+0.6%	$54.7B+4.6%	$57.3B+8.5%
Current Assets	$8.1B-9.5%	$8.0B-7.5%	$9.2B+6.1%	$9.3B-11.6%	$9.0B-26.3%	$8.7B-16.2%	$8.7B+6.2%	$10.5B+20.7%
Cash & Equivalents	$708.0M-3.7%	$813.0M+21.9%	$740.0M+4.1%	$567.0M-67.0%	$735.0M-83.5%	$667.0M-71.6%	$711.0M-39.7%	$1.7B+21.3%
Short-Term Investments	$1.0M-95.5%	$3.0M-81.3%	$11.0M-35.3%	$8.0M-98.2%	$22.0M-97.4%	$16.0M-98.1%	$17.0M+750.0%	$445.0M+5462.5%
Inventory	$3.3B-16.0%	$3.4B-9.8%	$4.1B+5.8%	$3.1B-18.1%	$3.9B+21.3%	$3.7B+15.3%	$3.9B+16.8%	$3.8B+17.4%
Accounts Receivable	$2.4B-19.7%	$2.2B-27.2%	$2.5B-4.9%	$2.4B-21.0%	$2.9B+13.4%	$3.0B+18.4%	$2.6B+16.4%	$3.0B+19.7%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$25.9B-2.5%	$26.0B-1.8%	$26.6B+1.1%	$26.0B-1.9%	$26.6B+8.4%	$26.4B+7.6%	$26.3B+7.0%	$26.5B+7.9%
Total Liabilities	$26.3B-10.6%	$26.7B-8.6%	$29.6B+0.3%	$29.9B-4.7%	$29.4B-1.0%	$29.2B+2.5%	$29.5B+9.3%	$31.4B+16.4%
Current Liabilities	$9.4B+15.2%	$8.5B+10.6%	$8.8B+14.3%	$8.3B-7.2%	$8.2B+23.5%	$7.7B+5.0%	$7.7B+1.6%	$9.0B+34.9%
Non-Current Liabilities	$16.9B-20.5%	$18.2B-15.5%	$20.8B-4.6%	$21.6B-3.6%	$21.3B-8.0%	$21.5B+1.7%	$21.8B+12.3%	$22.4B+10.3%
Long-Term Debt	$13.5B-22.9%	$14.7B-16.8%	$16.9B-3.0%	$17.6B-1.8%	$17.5B-3.3%	$17.7B+10.4%	$17.4B+23.7%	$17.9B+21.7%
Total Equity	$24.4B-4.1%	$24.1B-4.4%	$25.3B+0.3%	$25.4B-1.9%	$25.5B-1.5%	$25.2B-1.6%	$25.2B-0.5%	$25.9B+0.4%
Retained Earnings	$17.5B+6.6%	$17.4B+7.7%	$16.7B+3.5%	$16.6B+3.0%	$16.4B+2.6%	$16.1B+2.2%	$16.1B+3.9%	$16.1B+3.9%

BDX Cash Flow Statement

BDX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$4.0B	$3.4B-10.8%	$3.8B+28.6%	$3.0B+21.0%	$2.5B-46.8%	$4.6B+31.3%	$3.5B+6.3%	$3.3B+16.2%	$2.9B+12.4%	$2.5B-0.4%	$2.6B+47.9%	$1.7B-0.9%	$1.7B+1.7%	$1.7B+1.4%	$1.7B+3.4%	$1.6B
Depreciation & Amortization	N/A	$2.5B+7.7%	$2.3B-0.1%	$2.3B+2.6%	$2.2B0.0%	$2.2B+5.4%	$2.1B-6.1%	$2.3B+13.9%	$2.0B+81.8%	$1.1B-2.3%	$1.1B+25.0%	$891.0M+58.5%	$562.0M+2.9%	$546.0M+6.8%	$511.0M+3.4%	$494.0M
Stock-Based Compensation	N/A	$258.0M+4.5%	$247.0M-4.6%	$259.0M+11.2%	$233.0M+1.7%	$229.0M-3.0%	$236.0M-9.6%	$261.0M-18.9%	$322.0M+85.1%	$174.0M-11.2%	$196.0M+18.1%	$166.0M+46.9%	$113.0M+13.0%	$100.0M+12.4%	$89.0M+21.9%	$73.0M
Capital Expenditures	$753.0M	$760.0M+4.8%	$725.0M-17.0%	$874.0M-10.2%	$973.0M-18.5%	$1.2B+55.3%	$769.0M-19.6%	$957.0M+6.9%	$895.0M+23.1%	$727.0M+4.9%	$693.0M+16.3%	$596.0M+0.7%	$592.0M+13.4%	$522.0M+7.2%	$487.0M-4.3%	$509.0M
Free Cash Flow	$3.2B	$2.7B-14.4%	$3.1B+47.4%	$2.1B+41.3%	$1.5B-56.6%	$3.5B+24.7%	$2.8B+16.7%	$2.4B+20.5%	$2.0B+8.1%	$1.8B-2.3%	$1.9B+64.6%	$1.1B-1.7%	$1.2B-3.4%	$1.2B-0.9%	$1.2B+6.8%	$1.1B
Investing Cash Flow	N/A	-$818.0M+85.2%	-$5.5B-670.1%	-$716.0M	N/A	-$1.9B-52.6%	-$1.2B-66.3%	-$741.0M+95.3%	-$15.7B-1681.8%	-$883.0M-32.0%	-$669.0M+92.0%	-$8.3B-777.4%	-$948.0M	N/A	N/A	N/A
Financing Cash Flow	N/A	-$3.6B-273.3%	$2.1B+206.7%	-$2.0B	N/A	-$3.3B-15127.3%	$22.0M+100.7%	-$3.2B-5456.9%	-$58.0M-100.5%	$11.0B+723.3%	-$1.8B-128.4%	$6.2B+867.0%	-$807.0M	N/A	N/A	N/A
Dividends Paid	$1.2B	$1.2B+8.7%	$1.1B-1.3%	$1.1B+3.0%	$1.1B+3.2%	$1.0B+2.1%	$1.0B+4.3%	$984.0M+6.1%	$927.0M+36.9%	$677.0M+20.5%	$562.0M+15.9%	$485.0M+15.2%	$421.0M+9.1%	$386.0M+4.9%	$368.0M+1.9%	$361.0M
Share Buybacks	$2.5B	$1.0B+100.0%	$500.0M	$0-100.0%	$500.0M-71.4%	$1.8B	$0	$0	$0-100.0%	$220.0M	$0	$0-100.0%	$400.0M-11.1%	$450.0M-70.0%	$1.5B0.0%	$1.5B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$776.0M-28.7%	$671.0M+428.9%	$657.0M-5.2%	$1.9B+57.2%	$1.1B-16.0%	-$204.0M-139.7%	$693.0M-18.9%	$1.2B-11.1%
Depreciation & Amortization	$564.0M-1.9%	$563.0M-0.7%	$614.0M+1.2%	$756.0M+29.0%	$575.0M+1.2%	$567.0M-0.7%	$607.0M+8.2%	$586.0M-0.2%
Stock-Based Compensation	N/A	N/A	$91.0M+1.1%	N/A	N/A	N/A	$90.0M+8.4%	N/A
Capital Expenditures	$143.0M-12.8%	$125.0M+9.6%	$108.0M+2.9%	$377.0M+27.4%	$164.0M-8.4%	$114.0M-14.9%	$105.0M-9.5%	$296.0M+0.7%
Free Cash Flow	$633.0M-31.6%	$546.0M+271.7%	$549.0M-6.6%	$1.5B+67.2%	$925.0M-17.3%	-$318.0M-183.7%	$588.0M-20.4%	$882.0M-14.5%
Investing Cash Flow	N/A	N/A	-$183.0M-189.7%	-$494.0M+87.5%	-$336.0M-16.7%	-$192.0M+81.8%	$204.0M+187.6%	-$3.9B-2973.7%
Financing Cash Flow	N/A	N/A	-$302.0M+84.3%	-$809.0M-752.4%	-$841.0M-175.1%	-$39.0M-102.3%	-$1.9B-123.7%	$124.0M+112.4%
Dividends Paid	$286.0M-4.3%	$290.0M-2.7%	$299.0M-1.0%	$297.0M+8.0%	$299.0M+8.7%	$298.0M+8.4%	$302.0M+9.8%	$275.0M+3.8%
Share Buybacks	$0	$2.0B	$250.0M-66.7%	$250.0M	$0	$0	$750.0M+50.0%	$0

BDX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BDX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	45.4%+0.2pp	45.2%+3.0pp	42.2%-2.7pp	44.9%-0.2pp	45.1%-2.0pp	47.1%-0.8pp	47.9%+2.5pp	45.5%-3.7pp	49.1%+1.2pp	48.0%+2.3pp	45.7%-5.3pp	50.9%-0.9pp	51.8%+0.5pp	51.3%-0.9pp	52.2%
Operating Margin	11.8%-0.1pp	11.9%+1.0pp	10.9%-1.2pp	12.1%+0.3pp	11.8%+6.1pp	5.7%-4.5pp	10.2%+0.7pp	9.4%-3.2pp	12.6%+1.1pp	11.5%+1.0pp	10.4%-8.6pp	19.0%+3.4pp	15.6%-4.6pp	20.2%-1.8pp	22.0%
Net Margin	7.7%-0.8pp	8.5%+0.8pp	7.7%-1.8pp	9.4%-1.5pp	10.9%+5.5pp	5.4%-1.7pp	7.1%+5.2pp	1.9%-7.1pp	9.1%+1.3pp	7.8%+1.1pp	6.8%-7.3pp	14.0%-2.0pp	16.1%+0.9pp	15.2%-1.6pp	16.8%
Return on Equity	6.6%0.0pp	6.6%+0.8pp	5.8%-1.3pp	7.0%-1.8pp	8.8%+5.2pp	3.7%-2.2pp	5.9%+4.4pp	1.5%-7.0pp	8.5%-4.3pp	12.8%+3.1pp	9.7%-13.7pp	23.4%-2.2pp	25.6%-2.6pp	28.3%+2.0pp	26.3%
Return on Assets	3.0%+0.1pp	3.0%+0.2pp	2.8%-0.5pp	3.4%-0.5pp	3.9%+2.3pp	1.6%-0.8pp	2.4%+1.8pp	0.6%-2.3pp	2.9%-0.9pp	3.8%+1.2pp	2.6%-6.9pp	9.6%-1.1pp	10.6%+0.3pp	10.3%-1.9pp	12.2%
Current Ratio	1.11-0.1x	1.17-0.1x	1.31+0.3x	1.04-0.3x	1.33-0.2x	1.54+0.4x	1.18+0.2x	1.03-4.5x	5.58+4.1x	1.45+0.2x	1.29-1.5x	2.740.0x	2.76+0.1x	2.69+0.1x	2.56
Debt-to-Equity	0.690.0x	0.69+0.1x	0.570.0x	0.55-0.2x	0.720.0x	0.72-0.1x	0.860.0x	0.90-0.5x	1.44+0.1x	1.38-0.2x	1.59+0.8x	0.750.0x	0.75-0.2x	0.91+0.4x	0.51
Asset Turnover	0.390.0x	0.350.0x	0.370.0x	0.360.0x	0.36+0.1x	0.300.0x	0.330.0x	0.300.0x	0.32-0.2x	0.49+0.1x	0.39-0.3x	0.680.0x	0.660.0x	0.680.0x	0.73
FCF Margin	12.2%-3.2pp	15.5%+4.5pp	10.9%+3.0pp	7.9%-10.1pp	18.1%+0.8pp	17.2%+3.5pp	13.7%+1.4pp	12.3%-2.7pp	15.1%+0.1pp	14.9%+3.9pp	11.0%-2.6pp	13.7%-1.2pp	14.8%-0.8pp	15.7%+0.8pp	14.9%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	46.5%-0.8pp	45.7%+4.1pp	45.9%+2.7pp	48.1%+2.4pp	47.3%+1.1pp	41.5%-4.1pp	43.3%+0.2pp	45.7%+12.3pp
Operating Margin	13.3%-2.3pp	2.0%-6.6pp	10.5%+1.7pp	13.5%+2.0pp	15.6%+3.6pp	8.6%-6.0pp	8.8%-0.6pp	11.4%+4.6pp
Net Margin	7.6%-4.6pp	-6.6%-13.5pp	7.3%+1.4pp	6.6%-0.8pp	12.2%+2.4pp	6.9%-3.8pp	5.9%-0.1pp	7.4%+5.2pp
Return on Equity	1.5%-0.7pp	-1.3%-2.5pp	1.5%+0.3pp	1.9%+0.4pp	2.3%+0.4pp	1.2%-0.9pp	1.2%+0.1pp	1.5%+1.1pp
Return on Assets	0.7%-0.3pp	-0.6%-1.2pp	0.7%+0.2pp	0.9%+0.2pp	1.1%+0.2pp	0.6%-0.4pp	0.5%0.0pp	0.7%+0.5pp
Current Ratio	0.87-0.2x	0.94-0.2x	1.05-0.1x	1.11-0.1x	1.10-0.7x	1.13-0.3x	1.130.0x	1.17-0.1x
Debt-to-Equity	0.55-0.1x	0.61-0.1x	0.670.0x	0.690.0x	0.690.0x	0.70+0.1x	0.69+0.1x	0.69+0.1x
Asset Turnover	0.100.0x	0.090.0x	0.100.0x	0.130.0x	0.090.0x	0.080.0x	0.090.0x	0.090.0x
FCF Margin	12.7%-6.9pp	11.6%+18.7pp	10.4%-0.9pp	19.8%+3.5pp	19.6%-2.8pp	-7.1%-14.6pp	11.4%-4.3pp	16.2%-4.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Becton, Dickinson and Co. BDX	FY2025	$21.8B	$1.7B	7.7%	$48.2B	52/100
Alcon Inc. ALC	FY2010	$7.2B	$2.2B	30.8%	$30.9B	—
ResMed Inc. RMD	FY2026	$5.7B	$1.5B	26.9%	$31.9B	87/100
West Pharmaceutical Services, Inc. WST	FY2025	$3.1B	$493.7M	16.1%	$25.7B	76/100
Hologic Inc HOLX	FY2025	$4.1B	$565.7M	13.8%	$17.0B	69/100
Baxter International Inc. BAX	FY2025	$11.2B	-$957.0M	-8.5%	$12.2B	36/100

Where Becton, Dickinson and Co. Ranks

Frequently Asked Questions

What is Becton, Dickinson and Co.'s annual revenue?

Becton, Dickinson and Co. (BDX) reported $21.8B in total revenue for fiscal year 2025. This represents a 8.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Becton, Dickinson and Co.'s revenue growing?

Becton, Dickinson and Co. (BDX) revenue grew by 8.2% year-over-year, from $20.2B to $21.8B in fiscal year 2025.

Is Becton, Dickinson and Co. profitable?

Yes, Becton, Dickinson and Co. (BDX) reported a net income of $1.7B in fiscal year 2025, with a net profit margin of 7.7%.

What is Becton, Dickinson and Co.'s EBITDA?

Becton, Dickinson and Co. (BDX) had EBITDA of $5.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Becton, Dickinson and Co. have?

As of fiscal year 2025, Becton, Dickinson and Co. (BDX) had $567.0M in cash and equivalents against $17.6B in long-term debt.

What is Becton, Dickinson and Co.'s gross margin?

Becton, Dickinson and Co. (BDX) had a gross margin of 45.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Becton, Dickinson and Co.'s operating margin?

Becton, Dickinson and Co. (BDX) had an operating margin of 11.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Becton, Dickinson and Co.'s net profit margin?

Becton, Dickinson and Co. (BDX) had a net profit margin of 7.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Becton, Dickinson and Co. pay dividends?

Yes, Becton, Dickinson and Co. (BDX) paid $4.16 per share in dividends during fiscal year 2025.

What is Becton, Dickinson and Co.'s return on equity (ROE)?

Becton, Dickinson and Co. (BDX) has a return on equity of 6.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Becton, Dickinson and Co.'s free cash flow?

Becton, Dickinson and Co. (BDX) generated $2.7B in free cash flow during fiscal year 2025. This represents a -14.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Becton, Dickinson and Co.'s operating cash flow?

Becton, Dickinson and Co. (BDX) generated $3.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Becton, Dickinson and Co.'s total assets?

Becton, Dickinson and Co. (BDX) had $55.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Becton, Dickinson and Co.'s capital expenditures?

Becton, Dickinson and Co. (BDX) invested $760.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Becton, Dickinson and Co. spend on research and development?

Becton, Dickinson and Co. (BDX) invested $1.3B in research and development during fiscal year 2025.

Does Becton, Dickinson and Co. buy back shares?

Yes, Becton, Dickinson and Co. (BDX) spent $1.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Becton, Dickinson and Co. have outstanding?

Becton, Dickinson and Co. (BDX) had 285M shares outstanding as of fiscal year 2025.

What is Becton, Dickinson and Co.'s current ratio?

Becton, Dickinson and Co. (BDX) had a current ratio of 1.11 as of fiscal year 2025, which is considered adequate.

What is Becton, Dickinson and Co.'s debt-to-equity ratio?

Becton, Dickinson and Co. (BDX) had a debt-to-equity ratio of 0.69 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Becton, Dickinson and Co.'s return on assets (ROA)?

Becton, Dickinson and Co. (BDX) had a return on assets of 3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Becton, Dickinson and Co.'s P/E ratio?

Becton, Dickinson and Co. (BDX) trades at 51.2x earnings, its market capitalization divided by net income of $941.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $48.2B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Becton, Dickinson and Co.'s price-to-sales ratio?

Becton, Dickinson and Co. (BDX) trades at 2.1x sales, its market capitalization divided by revenue of $22.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $48.2B as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Becton, Dickinson and Co.'s Altman Z-Score?

Becton, Dickinson and Co. (BDX) has an Altman Z-Score of 1.95, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Becton, Dickinson and Co.'s Piotroski F-Score?

Becton, Dickinson and Co. (BDX) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Becton, Dickinson and Co.'s earnings high quality?

Becton, Dickinson and Co. (BDX) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Becton, Dickinson and Co. cover its interest payments?

Becton, Dickinson and Co. (BDX) has an interest coverage ratio of 4.21x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Becton, Dickinson and Co.?

Becton, Dickinson and Co. (BDX) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.